MEMORY GUNSARU: Open Payments
NPI 1891081303 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,823 in 120 payments from 26 companies in 2025. Trend: 2023 $1,286 · 2024 $1,984 · 2025 $1,823
Food & beverage: $1,823
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $269 |
| Novo Nordisk Inc | 13 | $242 |
| AstraZeneca Pharmaceuticals LP | 12 | $217 |
| Verona Pharma, Inc. | 12 | $158 |
| Lilly USA, LLC | 9 | $130 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $71 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 4 | $65 |
| Astellas Pharma US Inc | 3 | $64 |
| Sumitomo Pharma America, Inc. | 3 | $51 |
Products named: Ozempic, Ohtuvayre, BREZTRI, VRAYLAR, REXULTI, MOUNJARO, CAPLYTA, QULIPTA.
Industry payments across MO — which companies pay providers there.
